Cargando…

Talking about treatment benefits, harms, and what matters to patients in radiation oncology: an observational study

BACKGROUND: Shared decision making is associated with improved patient outcomes in radiation oncology. Our study aimed to capture how shared decision-making practices–namely, communicating potential harms and benefits and discussing what matters to patients–occur in usual care. METHODS: We invited a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilote, Laurie, Côté, Luc, Chipenda Dansokho, Selma, Brouillard, Émilie, Giguère, Anik M. C., Légaré, France, Grad, Roland, Witteman, Holly O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460774/
https://www.ncbi.nlm.nih.gov/pubmed/30975132
http://dx.doi.org/10.1186/s12911-019-0800-5
_version_ 1783410379042324480
author Pilote, Laurie
Côté, Luc
Chipenda Dansokho, Selma
Brouillard, Émilie
Giguère, Anik M. C.
Légaré, France
Grad, Roland
Witteman, Holly O.
author_facet Pilote, Laurie
Côté, Luc
Chipenda Dansokho, Selma
Brouillard, Émilie
Giguère, Anik M. C.
Légaré, France
Grad, Roland
Witteman, Holly O.
author_sort Pilote, Laurie
collection PubMed
description BACKGROUND: Shared decision making is associated with improved patient outcomes in radiation oncology. Our study aimed to capture how shared decision-making practices–namely, communicating potential harms and benefits and discussing what matters to patients–occur in usual care. METHODS: We invited a convenience sample of clinicians and patients in a radiation oncology clinic to participate in a mixed methods study. Prior to consultations, clinicians and patients completed self-administered questionnaires. We audio-recorded consultations and conducted qualitative content analysis. Patients completed a questionnaire immediately post-consultation about their recall and perceptions. RESULTS: 11 radiation oncologists, 4 residents, 14 nurses, and 40 patients (55% men; mean age 64, standard deviation or SD 9) participated. Patients had a variety of cancers; 30% had been referred for palliative radiotherapy. During consultations (mean length 45 min, SD 16), clinicians presented a median of 8 potential harms (interquartile range 6–11), using quantitative estimates 17% of the time. Patients recalled significantly fewer harms (median recall 2, interquartile range 0–3, t(38) = 9.3, p < .001). Better recall was associated with discussing potential harms with a nurse after seeing the physician (odds ratio 7.5, 95% confidence interval 1.3–67.0, p = .04.) Clinicians initiated 63% of discussions of harms and benefits while patients and families initiated 69% of discussions about values and preferences (Chi-squared(1) = 37.8, p < .001). 56% of patients reported their clinician asked what mattered to them. CONCLUSIONS: Radiation oncology clinics may wish to use interprofessional care and initiate more discussions about what matters to patients to heed Jain’s (2014) reminder that, “a patient isn’t a disease with a body attached but a life into which a disease has intruded.”
format Online
Article
Text
id pubmed-6460774
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64607742019-05-01 Talking about treatment benefits, harms, and what matters to patients in radiation oncology: an observational study Pilote, Laurie Côté, Luc Chipenda Dansokho, Selma Brouillard, Émilie Giguère, Anik M. C. Légaré, France Grad, Roland Witteman, Holly O. BMC Med Inform Decis Mak Research Article BACKGROUND: Shared decision making is associated with improved patient outcomes in radiation oncology. Our study aimed to capture how shared decision-making practices–namely, communicating potential harms and benefits and discussing what matters to patients–occur in usual care. METHODS: We invited a convenience sample of clinicians and patients in a radiation oncology clinic to participate in a mixed methods study. Prior to consultations, clinicians and patients completed self-administered questionnaires. We audio-recorded consultations and conducted qualitative content analysis. Patients completed a questionnaire immediately post-consultation about their recall and perceptions. RESULTS: 11 radiation oncologists, 4 residents, 14 nurses, and 40 patients (55% men; mean age 64, standard deviation or SD 9) participated. Patients had a variety of cancers; 30% had been referred for palliative radiotherapy. During consultations (mean length 45 min, SD 16), clinicians presented a median of 8 potential harms (interquartile range 6–11), using quantitative estimates 17% of the time. Patients recalled significantly fewer harms (median recall 2, interquartile range 0–3, t(38) = 9.3, p < .001). Better recall was associated with discussing potential harms with a nurse after seeing the physician (odds ratio 7.5, 95% confidence interval 1.3–67.0, p = .04.) Clinicians initiated 63% of discussions of harms and benefits while patients and families initiated 69% of discussions about values and preferences (Chi-squared(1) = 37.8, p < .001). 56% of patients reported their clinician asked what mattered to them. CONCLUSIONS: Radiation oncology clinics may wish to use interprofessional care and initiate more discussions about what matters to patients to heed Jain’s (2014) reminder that, “a patient isn’t a disease with a body attached but a life into which a disease has intruded.” BioMed Central 2019-04-11 /pmc/articles/PMC6460774/ /pubmed/30975132 http://dx.doi.org/10.1186/s12911-019-0800-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pilote, Laurie
Côté, Luc
Chipenda Dansokho, Selma
Brouillard, Émilie
Giguère, Anik M. C.
Légaré, France
Grad, Roland
Witteman, Holly O.
Talking about treatment benefits, harms, and what matters to patients in radiation oncology: an observational study
title Talking about treatment benefits, harms, and what matters to patients in radiation oncology: an observational study
title_full Talking about treatment benefits, harms, and what matters to patients in radiation oncology: an observational study
title_fullStr Talking about treatment benefits, harms, and what matters to patients in radiation oncology: an observational study
title_full_unstemmed Talking about treatment benefits, harms, and what matters to patients in radiation oncology: an observational study
title_short Talking about treatment benefits, harms, and what matters to patients in radiation oncology: an observational study
title_sort talking about treatment benefits, harms, and what matters to patients in radiation oncology: an observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460774/
https://www.ncbi.nlm.nih.gov/pubmed/30975132
http://dx.doi.org/10.1186/s12911-019-0800-5
work_keys_str_mv AT pilotelaurie talkingabouttreatmentbenefitsharmsandwhatmatterstopatientsinradiationoncologyanobservationalstudy
AT coteluc talkingabouttreatmentbenefitsharmsandwhatmatterstopatientsinradiationoncologyanobservationalstudy
AT chipendadansokhoselma talkingabouttreatmentbenefitsharmsandwhatmatterstopatientsinradiationoncologyanobservationalstudy
AT brouillardemilie talkingabouttreatmentbenefitsharmsandwhatmatterstopatientsinradiationoncologyanobservationalstudy
AT giguereanikmc talkingabouttreatmentbenefitsharmsandwhatmatterstopatientsinradiationoncologyanobservationalstudy
AT legarefrance talkingabouttreatmentbenefitsharmsandwhatmatterstopatientsinradiationoncologyanobservationalstudy
AT gradroland talkingabouttreatmentbenefitsharmsandwhatmatterstopatientsinradiationoncologyanobservationalstudy
AT wittemanhollyo talkingabouttreatmentbenefitsharmsandwhatmatterstopatientsinradiationoncologyanobservationalstudy